Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway
Open Access
- 1 May 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 296 (5), F983-F993
- https://doi.org/10.1152/ajprenal.90579.2008
Abstract
Nephrotoxicity is the major limiting factor for the use of cisplatin in cancer therapy. Recent studies have demonstrated an important role for p53 in cisplatin-induced renal injury. Nevertheless, pharmacological and genetic blockade of p53 only provides partial renoprotective effects, suggesting the presence of p53-independent injury mechanisms. To understand the p53-independent mechanisms, we have now examined cisplatin-induced apoptosis in p53-deficient kidney cells. We show that cisplatin could induce Bax activation, cytochrome c release, and apoptosis in primary cultures of p53-deficient renal tubular cells, albeit at a level that was lower than in the wild-type cells. Cisplatin could also induce typical apoptosis in p53-deficient baby mouse kidney (BMK) cells. The apoptosis was caspase dependent and could be completely blocked by general caspase inhibitors. Bax and Bak, two key molecules in the mitochondrial pathway of apoptosis, were interdependently activated by cisplatin, with Bax translocation to and Bax/Bak oligomerization in mitochondria, leading to cytochrome c release. Importantly, cytochrome c release and apoptosis were diminished in Bax/Bak single or double-knockout BMK cells. Furthermore, overexpression of Bcl-2 could ameliorate cisplatin-induced cytochrome c release and apoptosis. Together, the results have demonstrated a p53-independent mechanism of cisplatin nephrotoxicity that involves the mitochondrial pathway of apoptosis.Keywords
This publication has 42 references indexed in Scilit:
- Regulation and Pathological Role of p53 in Cisplatin NephrotoxicityJournal of Pharmacology and Experimental Therapeutics, 2008
- Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastineMolecular Cancer Therapeutics, 2008
- Activation and involvement of p53 in cisplatin-induced nephrotoxicityAmerican Journal of Physiology-Renal Physiology, 2007
- Nutlin-3 Protects Kidney Cells during Cisplatin Therapy by Suppressing Bax/Bak ActivationPublished by Elsevier BV ,2007
- Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicityBiochemical Pharmacology, 2007
- Protein kinase PKC delta and c‐Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptorFEBS Letters, 2006
- Regulation of TauT by cisplatin in LLC-PK1 renal cellsPediatric Nephrology, 2005
- Cell DeathCell, 2004
- Inhibition of Bid-induced Apoptosis by Bcl-2Published by Elsevier BV ,2003
- Association of Bax and Bak Homo-oligomers in MitochondriaPublished by Elsevier BV ,2003